SCHAEFFER LEONARD D 4
4 · scPharmaceuticals Inc. · Filed Aug 28, 2024
Insider Transaction Report
Form 4
SCHAEFFER LEONARD D
Director
Transactions
- Exercise/Conversion
Common Stock
2024-08-26$3.37/sh+6,124$20,638→ 54,451 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-26−6,124→ 0 totalExercise: $3.37Exp: 2029-06-18→ Common Stock (6,124 underlying) - Exercise/Conversion
Common Stock
2024-08-26$1.66/sh+5,223$8,670→ 48,327 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-26−5,223→ 0 totalExercise: $1.66Exp: 2024-09-17→ Common Stock (5,223 underlying)
Footnotes (1)
- [F1]The option is fully vested.